Legend Biotech (LEGN) earnings, May 12, 2026: EPS +44%, stock +10.5%
In brief
Legend Biotech reported on May 12, 2026. Earnings per share changed +44% year over year, 1,320.6% below the estimate; revenue +56%. The stock opened with a −3.7% gap and closed the day +10.5% (May 12, 2026). The stock is now 39.9% below its 52-week high, −29.6% over 12 months. Next report: Nov 10, 2026.
EPS vs estimate−1,320.6%
EPS, YoY+44%
Revenue, YoY+56%
Gap · day−3.7% · +10.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 12, 2026 | −3.7% | +10.5% |
Next-quarter estimates, ratings and the LEGN chart are in the terminal.
Open the terminalFAQ
When is Legend Biotech's next earnings report?
Nov 10, 2026. The date comes from daily data and is corrected if the company moves it.
How did Legend Biotech stock react to the report?
Opening gap −3.7%, day's result +10.5%.
Did Legend Biotech's earnings grow?
Earnings per share rose 44% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.